Clinical trial
BIOTRONIK-A Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two de Novo Coronary Artery Lesions - IV
NCT01939249 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIOTRONIK-A Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two de Novo Coronary Artery Lesions - IV
- Lead sponsor
- Biotronik AG
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- January 31, 2020
- Enrollment
- 585 (estimated)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.